Webcast Discusses Pharmacologic Management of Pain

OSUWexnerbloglogo2014 Webcast Discusses Pharmacologic Management of Pain. We now know that opioid pain medications prescribed excessively are addictive and can abscond with our patients’ careers, their futures, and even their lives. But if we don’t treat their pain, then physicians are treated as professional failures. Well, on this CME webcast, we’re going to help you navigate pain. The goal is to set realistic expectations to manage your patients’ pain without turning their lives into a nightmare of addiction and despair. Joining our moderator in the studio is pain management expert and specialty practice pharmacist from the OSU Wexner Medical Center, Lisa Mostafavifar.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS multi-modal pharmacologic treatment options for patients with acute and/or chronic pain; and REVIEW guidelines for acute and chronic pain management that may help curb the misuse and abuse of prescription pain medication.

You’ll also learn about the following:

  • Non-opioid pain management options
  • Setting realistic goals for pain control in the hospital
  • Opioid addiction following opioid prescriptions

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Primary Care Physicians Learn about Oropharyngeal Cancer on Webcast

OSUWexnerbloglogo2014 Primary Care Physicians Learn about Oropharyngeal Cancer on Webcast. On this CME webcast, we’re going to learn about oropharyngeal cancer, what causes it, how to treat it, and how to prevent it. We’re pleased to welcome head and neck cancer specialist and Assistant Professor of Otolaryngology, Dr. Stephen Kang.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common patterns of clinical presentation of oropharynx cancer; and RECOGNIZE the role of HPV in the development of oropharynx cancer, and the way HPV has changed head and neck cancer.

You’ll also learn about the following:

  • Diagnostic challenges of oropharyngeal cancer
  • Causes of oropharyngeal cancer
  • Laryngeal cancer versus oropharyngeal cancer
  • Non-squamous cell oropharyngeal cancers
  • Parotid gland tumors
  • Dysphagia after oropharyngeal cancer treatment
  • Speech and taste after oropharyngeal cancer treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches on Anticoagulation and New Anticoagulants

OSUWexnerbloglogo2014 Webcast Teaches on Anticoagulation and New Anticoagulants. Now, we have even more anticoagulants and with all of the choices comes a lot of confusion. On this CME webcast, joining our moderator, to demystify all of the new anticoagulants and to give us some direction of when to choose one versus another is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Tzu-Fei Wang.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: State the differences of old anticoagulation and new direct oral anticoagulants and know the four approved direct oral anticoagulant; and UNDERSTAND the indications, laboratory testing, and precautions when prescribing direct oral anticoagulants.

You’ll also learn about the following:

  • The problem with Coumadin
  • Currently available direct oral anticoagulants
  • When Coumadin is the best option
  • Mitigating malpractice risk when prescribing direct oral anticoagulants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Discussing Multiple Myeloma

OSUWexnerbloglogo2014 On-line CME Discussing Multiple Myeloma. In the past year, there have been 4 new drugs approved to treat multiple myeloma and these are changing the way that we manage patients with this disease. On this CME webcast, we’re going to talk about what multiple myeloma is, how you diagnosis it, and how it is treated. Joining our moderator in the studio is hematologist and Assistant Professor of Internal Medicine from the OSU Wexner Medical Center, Dr. Ashley Rosko. And also from the division of hematology, we have Associate Professor of Internal Medicine, Dr. Yvonne Efebera joining us.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between MGUS, smoldering Myeloma, Symptomatic multiple Myeloma; DESCRIBE the general clinical features of plasma cell myeloma including the diagnosis, and steps required for evaluation; UNDERSTAND Treatment strategy for Newly diagnosed Multiple Myeloma Patients Eligible for Transplant and Newly diagnosed Multiple Myeloma Patients not Eligible for Transplant.

You’ll also learn about the following:

  • Epidemiology of multiple myeloma
  • Prognosis of multiple myeloma
  • When to do a bone marrow biopsy?
  • Screening patients with kidney failure for multiple myeloma
  • Management of hypercalcemia and renal failure in multiple myeloma
  • Autologous versus allogenic stem cell transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME for Immigrant Medicine

OSUWexnerbloglogo2014 On-line CME for Immigrant Medicine. On this CME webcast, we’re going to take a close up look at the process of immigration from the physician’s perspective. What medical evaluations immigrants have to undergo and what healthcare workers need to know about the immigration process. Joining our moderator in the studio is Assistant Professor of Internal Medicine, Dr. Mark Troyer

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the major types of immigration to the US, with focus on the origins of refugees arriving in Ohio; and OUTLINE the framework of medical screening that occurs inside and outside the US during immigration.

You’ll also learn about the following:

  • Why people immigrate
  • Immigrant populations in Columbus, Ohio
  • Interpreter services
  • PPD versus Quantiferon
  • Cultural differences in end-of-life care
  • Medical implications of undocumented immigrants
  • Integrating traditional medicine with Western medicine
  • Health insurance for non-citizens
  • Immigrants requiring dialysis and other chronic medical treatments

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.